Sara Napoli
7PUBLICATIONS
55CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Jul 14, 2025
IL-16 production is a mechanism of resistance to BTK inhibitors and R-CHOP in lymphomas.Alberto J Arribas, Francesca Guidetti, Eleonora Cannas
|Oct 07, 2024
PI3Kδ activation, IL-6 overexpression, and CD37 loss cause resistance to naratuximab emtansine in lymphomas.Alberto J Arribas, Sara Napoli, Eugenio Gaudio
|Dec 05, 2023
ERBB4-Mediated Signaling Is a Mediator of Resistance to PI3K and BTK Inhibitors in B-cell Lymphoid Neoplasms.Alberto J Arribas, Sara Napoli, Luciano Cascione
|Nov 28, 2023
PI3Kδ activation, IL6 over-expression, and CD37 loss cause resistance to the targeting of CD37-positive lymphomas with the antibody-drug conjugate naratuximab emtansine.Alberto J Arribas, Eugenio Gaudio, Sara Napoli
|Apr 17, 2023
IOA-244 is a Non-ATP-competitive, Highly Selective, Tolerable PI3K Delta Inhibitor That Targets Solid Tumors and Breaks Immune Tolerance.Zoë Johnson, Chiara Tarantelli, Elisa Civanelli
|Jan 30, 2023
ERBB4-mediated signaling is a mediator of resistance to BTK and PI3K inhibitors in B cell lymphoid neoplasms.Alberto J Arribas, Sara Napoli, Luciano Cascione
Pageof 2
Frequent Collaborators
7 joint publications
Chiara Tarantelli
7 joint publications
Luciano Cascione
7 joint publications
Francesco Bertoni
5 joint publications
Georg Stussi
5 joint publications
Andrea Rinaldi
5 joint publications
Emanuele Zucca
5 joint publications
Alberto J Arribas
4 joint publications
Filippo Spriano
3 joint publications
Francesca M Rossi
3 joint publications
Giulio Sartori
